212 related articles for article (PubMed ID: 30051460)
1. In situ and invasive melanoma in a high-risk, New Zealand, population: A population-based study.
Elwood JM; Kim SJ; Ip KH; Oakley A; Rademaker M
Australas J Dermatol; 2019 Feb; 60(1):38-44. PubMed ID: 30051460
[TBL] [Abstract][Full Text] [Related]
2. Distribution of subsequent primary invasive melanomas following a first primary invasive or in situ melanoma Queensland, Australia, 1982-2010.
Youlden DR; Youl PH; Soyer HP; Aitken JF; Baade PD
JAMA Dermatol; 2014 May; 150(5):526-34. PubMed ID: 25093216
[TBL] [Abstract][Full Text] [Related]
3. Primary malignant melanoma of skin in four regions of New Zealand.
Cooke K; McNoe B; Hursthouse M; Taylor R
N Z Med J; 1992 Aug; 105(939):303-6. PubMed ID: 1501812
[TBL] [Abstract][Full Text] [Related]
4. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
5. Increasing time trends of thin melanomas in The Netherlands: What are the explanations of recent accelerations?
van der Leest RJ; Zoutendijk J; Nijsten T; Mooi WJ; van der Rhee JI; de Vries E; Hollestein LM
Eur J Cancer; 2015 Dec; 51(18):2833-41. PubMed ID: 26589973
[TBL] [Abstract][Full Text] [Related]
6. Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002.
Coory M; Baade P; Aitken J; Smithers M; McLeod GR; Ring I
Cancer Causes Control; 2006 Feb; 17(1):21-7. PubMed ID: 16411049
[TBL] [Abstract][Full Text] [Related]
7. Clinical and histological features of head and neck melanoma: a population-based study in France.
Dabouz F; Barbe C; Lesage C; Le Clainche A; Arnoult G; Hibon E; Bernard P; Grange F
Br J Dermatol; 2015 Mar; 172(3):707-15. PubMed ID: 25333719
[TBL] [Abstract][Full Text] [Related]
8. Clinical Features Associated With Individuals at Higher Risk of Melanoma: A Population-Based Study.
Watts CG; Madronio C; Morton RL; Goumas C; Armstrong BK; Curtin A; Menzies SW; Mann GJ; Thompson JF; Cust AE
JAMA Dermatol; 2017 Jan; 153(1):23-29. PubMed ID: 27829101
[TBL] [Abstract][Full Text] [Related]
9. Changes in the site distribution of common melanoma subtypes in Queensland, Australia over time: implications for public health campaigns.
Youl PH; Youlden DR; Baade PD
Br J Dermatol; 2013 Jan; 168(1):136-44. PubMed ID: 22612718
[TBL] [Abstract][Full Text] [Related]
10. The thickness of melanomas has decreased in central Italy, but only for thin melanomas, while thick melanomas are as thick as in the past.
Crocetti E; Caldarella A; Chiarugi A; Nardini P; Zappa M
Melanoma Res; 2010 Oct; 20(5):422-6. PubMed ID: 20679908
[TBL] [Abstract][Full Text] [Related]
11. Incidence of In Situ and Invasive Melanoma in Denmark From 1985 Through 2012: A National Database Study of 24,059 Melanoma Cases.
Helvind NM; Hölmich LR; Smith S; Glud M; Andersen KK; Dalton SO; Drzewiecki KT
JAMA Dermatol; 2015 Oct; 151(10):1087-95. PubMed ID: 26061591
[TBL] [Abstract][Full Text] [Related]
12. Population-based incidence and melanoma-specific survival of cutaneous malignant melanoma in a Colombian population 2000-2009.
Reyes E; Uribe C; de Vries E
Int J Dermatol; 2018 Jan; 57(1):21-27. PubMed ID: 29231241
[TBL] [Abstract][Full Text] [Related]
13. Comparison between lentigo maligna melanoma and other histogenetic types of malignant melanoma of the head and neck. Scottish Melanoma Group.
Cox NH; Aitchison TC; Sirel JM; MacKie RM
Br J Cancer; 1996 Apr; 73(7):940-4. PubMed ID: 8611411
[TBL] [Abstract][Full Text] [Related]
14. The anatomic distribution of cutaneous melanoma: A detailed study of 5141 lesions.
Wee E; Wolfe R; Mclean C; Kelly JW; Pan Y
Australas J Dermatol; 2020 May; 61(2):125-133. PubMed ID: 31880825
[TBL] [Abstract][Full Text] [Related]
15. Extremely high levels of melanoma in Tauranga, New Zealand: possible causes and comparisons with Australia and the northern hemisphere.
Salmon PJ; Chan WC; Griffin J; McKenzie R; Rademaker M
Australas J Dermatol; 2007 Nov; 48(4):208-16. PubMed ID: 17956477
[TBL] [Abstract][Full Text] [Related]
16. Melanoma in Western Australia in 1980-81: incidence and characteristics of histological types.
English DR; Heenan PJ; Holman CD; Armstrong BK; Blackwell JB; Kelsall GR; Matz LR; Singh A; Ten Seldam RE
Pathology; 1987 Oct; 19(4):383-92. PubMed ID: 3444664
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous melanoma in New Zealand: 2000-2004.
Liang JJ; Robinson E; Martin RC
ANZ J Surg; 2010 May; 80(5):312-6. PubMed ID: 20557503
[TBL] [Abstract][Full Text] [Related]
18. Incidence of malignant melanoma in Auckland, New Zealand: highest rates in the world.
Jones WO; Harman CR; Ng AK; Shaw JH
World J Surg; 1999 Jul; 23(7):732-5. PubMed ID: 10390596
[TBL] [Abstract][Full Text] [Related]
19. Incidence trends and clinical-pathological characteristics of invasive cutaneous melanoma from 1980 to 2010 in the Canton of Zurich, Switzerland.
Minini R; Rohrmann S; Braun R; Korol D; Dehler S
Melanoma Res; 2017 Apr; 27(2):145-151. PubMed ID: 27926588
[TBL] [Abstract][Full Text] [Related]
20. Malignant melanoma of the head and neck in Scotland: an eight-year analysis of trends in prevalence, distribution and prognosis.
Cox NH; Jones SK; MacKie RM
Q J Med; 1987 Aug; 64(244):661-70. PubMed ID: 3444872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
